Genomma Lab Internacional, S.A.B. de C.V. (OTCMKTS:GNMLF – Get Free Report) saw a large decline in short interest in May. As of May 15th, there was short interest totaling 2,031,410 shares, a decline of 45.7% from the April 30th total of 3,744,107 shares. Based on an average trading volume of 3,636 shares, the days-to-cover ratio is currently 558.7 days.
Genomma Lab Internacional Price Performance
OTCMKTS:GNMLF opened at $1.08 on Monday. Genomma Lab Internacional has a fifty-two week low of $0.91 and a fifty-two week high of $1.27. The stock’s 50-day moving average is $1.04 and its two-hundred day moving average is $1.02.
Genomma Lab Internacional Company Profile
Genomma Lab Internacional, SAB. de C.V. is a Mexico City–based consumer healthcare company that develops, markets and distributes over-the-counter (OTC) pharmaceuticals, personal care products and beauty solutions. Since its founding in 1996, the firm has built a diversified portfolio encompassing topical analgesics, cold and flu remedies, digestive health treatments, skin and hair care lines, and nutritional supplements. Its product mix blends proprietary brands with licensed formulas, targeting everyday wellness and self-care needs.
The company’s growth strategy hinges on intensive marketing campaigns, including television infomercials, digital advertising and direct‐to‐consumer promotions.
Featured Articles
- Five stocks we like better than Genomma Lab Internacional
- Palantir Stock Faces Technical Pressure Despite Strong AI Growth
- These 3 CLO ETFs Target a Niche Corner of the Fixed-Income Market
- 3 Ways to Play the Data Center Land Grab
- The Smarter Way to Invest in AI Without Taking Extreme Risk
Receive News & Ratings for Genomma Lab Internacional Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genomma Lab Internacional and related companies with MarketBeat.com's FREE daily email newsletter.
